Literature DB >> 11122155

Haemochromatosis in patients with beta-thalassaemia trait.

A Piperno1, R Mariani, C Arosio, A Vergani, S Bosio, S Fargion, M Sampietro, D Girelli, M Fraquelli, D Conte, G Fiorelli, C Camaschella.   

Abstract

Severe iron overload has been reported in patients with the beta-thalassaemia trait. Studies performed before the discovery of the haemochromatosis gene (HFE) have yielded conflicting results: some suggest that iron overload might arise from the interaction of the beta-thalassaemia trait with heterozygosity for haemochromatosis, some with homozygosity for haemochromatosis and others that it was unrelated to haemochromatosis. We have studied the clinical phenotype, iron indices and HFE genotypes of 22 unrelated patients with the beta-thalassaemia trait and haemochromatosis, the inheritance of chromosome 6p and 1q haplotypes in families of non-homozygous C282Y probands and serum measures of iron status in relatives heterozygous for C282Y with or without the beta-thalassaemia trait. We demonstrate that the beta-thalassaemia trait aggravates the clinical picture of C282Y homozygotes, favouring higher rates of iron accumulation and the development of severe iron-related complications. We suggest that the coexistence of the beta-thalassaemia trait might also increase the risk of iron overload in patients with HFE genotypes at a mild risk of haemochromatosis. Our findings do not support the hypothesis that the association of the beta-thalassaemia trait with a single C282Y or H63D allele might lead to iron overload and suggest that other non-HFE-related inherited factors are present in haemochromatosis patients with incomplete HFE genotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122155

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.

Authors:  Elena Canavesi; Carlo Alfieri; Serena Pelusi; Luca Valenti
Journal:  World J Nephrol       Date:  2012-12-06

Review 2.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Authors:  Luca Valenti; Paolo Maggioni; Alberto Piperno; Raffaela Rametta; Sara Pelucchi; Raffaella Mariani; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

4.  The role of HFE mutations on iron metabolism in beta-thalassemia carriers.

Authors:  Rute Martins; Isabel Picanço; Aidil Fonseca; Lídia Ferreira; Odete Rodrigues; Marília Coelho; Teresa Seixas; Armandina Miranda; Baltazar Nunes; Luciana Costa; Luísa Romão; Paula Faustino
Journal:  J Hum Genet       Date:  2004-11-05       Impact factor: 3.172

Review 5.  Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.

Authors:  James E Nelson; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 6.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

7.  Effect of the Hemochromatosis Mutations on Iron Overload among the Indian β Thalassemia Carriers.

Authors:  Anita H Nadkarni; Aradhana A Singh; Stacy Colaco; Priya Hariharan; Roshan B Colah; Kanjaksha Ghosh
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

8.  Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation.

Authors:  M De Gobbi; R Caruso; F Daraio; F Chianale; R M Pinto; F Longo; A Piga; C Camaschella
Journal:  Eur J Pediatr       Date:  2002-12-10       Impact factor: 3.183

9.  Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis.

Authors:  Serena Pelusi; Federica Iuculano; Rosa Lombardi; Paolo Francione; Umberto Gianelli; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Intern Emerg Med       Date:  2018-09-14       Impact factor: 3.397

10.  Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Authors:  Emma Jones; Sant-Rayn Pasricha; Angela Allen; Patricia Evans; Chris A Fisher; Katherine Wray; Anuja Premawardhena; Dyananda Bandara; Ashok Perera; Craig Webster; Pamela Sturges; Nancy F Olivieri; Timothy St Pierre; Andrew E Armitage; John B Porter; David J Weatherall; Hal Drakesmith
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.